Consistent glycaemic efficacy and safety of concomitant use of iGlarLixi and sodium-glucose co-transporter-2 inhibitor therapy for type 2 diabetes: A patient-level pooled analysis of three randomised clinical trials

Autor: Giorgino, Francesco, Guja, Cristian, Aydın, Hasan, Lauand, Felipe, Melas-Melt, Lydie, Rosenstock, Julio
Zdroj: In Diabetes Research and Clinical Practice March 2024 209
Databáze: ScienceDirect